{"id":1957,"date":"2022-02-10T23:24:33","date_gmt":"2022-02-10T16:24:33","guid":{"rendered":"https:\/\/udibi6748.live-website.com\/?page_id=1957"},"modified":"2022-02-10T23:25:05","modified_gmt":"2022-02-10T16:25:05","slug":"development-of-therapeutic-anti-tnf-antibodies","status":"publish","type":"page","link":"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/","title":{"rendered":"Development of therapeutic anti-TNF antibodies"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row padding_top=&#8221;10&#8243; padding_bottom=&#8221;10&#8243;][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#a1bf3b&#8221;][vc_custom_heading text=&#8221;Development of therapeutic anti-TNF antibodies&#8221; font_container=&#8221;tag:h3|font_size:25|text_align:left|color:%230d1250&#8243; google_fonts=&#8221;font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal&#8221; css=&#8221;.vc_custom_1644510127017{margin-top: 1px !important;padding-top: 10px !important;}&#8221;][vc_column_text]<\/p>\n<p style=\"text-align: justify;\">The development of specific antibodies against TNF-\u03b1 will make it possible to reduce the cost of biological drugs in the Basic Table of Medicines and thus, provide access to cutting-edge products (therapeutic antibodies) and therapies to the Mexican and worldwide population.<\/p>\n<p style=\"text-align: justify;\">This project will allow the development of innovative therapeutic antibodies (anti-TNF-\u03b1) from Mexico. To substitute with an anti-TNF-\u03b1 product made in Mexico several of the therapeutic antibodies of the Basic Table of Medications.<\/p>\n<p style=\"text-align: justify;\">In our institution, we have a solid technological platform for the discovery of therapeutic antibodies, which involves a rigorous selection process based on stability, affinity and specificity. This state-of-the-art platform, unique in Mexico, can be used to isolate antibodies for different purposes in the diagnosis and treatment of diseases.<\/p>\n<p style=\"text-align: justify;\">So far we have a set of anti-TNF-\u03b1 antibodies from ALTHEA Gold Libraries\u2122. Some of these antibodies have neutralizing and blocking capacity against membranal TNF. We have selected a leading antibody that has been improved through affinity optimization processes, with the aim of obtaining an antibody similar to or better than others currently used in the clinic.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row padding_top=&#8221;10&#8243; padding_bottom=&#8221;10&#8243;][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#a1bf3b&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row padding_top=&#8221;10&#8243; padding_bottom=&#8221;10&#8243;][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#a1bf3b&#8221;][vc_custom_heading text=&#8221;Development of therapeutic anti-TNF antibodies&#8221; font_container=&#8221;tag:h3|font_size:25|text_align:left|color:%230d1250&#8243; google_fonts=&#8221;font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal&#8221; css=&#8221;.vc_custom_1644510127017{margin-top: 1px !important;padding-top: 10px !important;}&#8221;][vc_column_text] The development of specific antibodies against TNF-\u03b1 will make it possible to reduce the cost of biological drugs in the Basic Table of Medicines and thus, provide access to cutting-edge products (therapeutic antibodies) and therapies to the Mexican and worldwide population. This project [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"pmpro_default_level":"","footnotes":""},"class_list":["post-1957","page","type-page","status-publish","hentry","pmpro-has-access"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Development of therapeutic anti-TNF antibodies - UDIBI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Development of therapeutic anti-TNF antibodies - UDIBI\" \/>\n<meta property=\"og:description\" content=\"[vc_row padding_top=&#8221;10&#8243; padding_bottom=&#8221;10&#8243;][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#a1bf3b&#8221;][vc_custom_heading text=&#8221;Development of therapeutic anti-TNF antibodies&#8221; font_container=&#8221;tag:h3|font_size:25|text_align:left|color:%230d1250&#8243; google_fonts=&#8221;font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal&#8221; css=&#8221;.vc_custom_1644510127017{margin-top: 1px !important;padding-top: 10px !important;}&#8221;][vc_column_text] The development of specific antibodies against TNF-\u03b1 will make it possible to reduce the cost of biological drugs in the Basic Table of Medicines and thus, provide access to cutting-edge products (therapeutic antibodies) and therapies to the Mexican and worldwide population. This project [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIBI\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-10T16:25:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/\",\"url\":\"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/\",\"name\":\"Development of therapeutic anti-TNF antibodies - UDIBI\",\"isPartOf\":{\"@id\":\"https:\/\/udibi.com.mx\/en\/#website\"},\"datePublished\":\"2022-02-10T16:24:33+00:00\",\"dateModified\":\"2022-02-10T16:25:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/udibi.com.mx\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Development of therapeutic anti-TNF antibodies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udibi.com.mx\/en\/#website\",\"url\":\"https:\/\/udibi.com.mx\/en\/\",\"name\":\"UDIBI\",\"description\":\"IPN\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udibi.com.mx\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Development of therapeutic anti-TNF antibodies - UDIBI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/","og_locale":"en_US","og_type":"article","og_title":"Development of therapeutic anti-TNF antibodies - UDIBI","og_description":"[vc_row padding_top=&#8221;10&#8243; padding_bottom=&#8221;10&#8243;][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#a1bf3b&#8221;][vc_custom_heading text=&#8221;Development of therapeutic anti-TNF antibodies&#8221; font_container=&#8221;tag:h3|font_size:25|text_align:left|color:%230d1250&#8243; google_fonts=&#8221;font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal&#8221; css=&#8221;.vc_custom_1644510127017{margin-top: 1px !important;padding-top: 10px !important;}&#8221;][vc_column_text] The development of specific antibodies against TNF-\u03b1 will make it possible to reduce the cost of biological drugs in the Basic Table of Medicines and thus, provide access to cutting-edge products (therapeutic antibodies) and therapies to the Mexican and worldwide population. This project [&hellip;]","og_url":"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/","og_site_name":"UDIBI","article_modified_time":"2022-02-10T16:25:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/","url":"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/","name":"Development of therapeutic anti-TNF antibodies - UDIBI","isPartOf":{"@id":"https:\/\/udibi.com.mx\/en\/#website"},"datePublished":"2022-02-10T16:24:33+00:00","dateModified":"2022-02-10T16:25:05+00:00","breadcrumb":{"@id":"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/udibi.com.mx\/en\/development-of-therapeutic-anti-tnf-antibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/udibi.com.mx\/en\/"},{"@type":"ListItem","position":2,"name":"Development of therapeutic anti-TNF antibodies"}]},{"@type":"WebSite","@id":"https:\/\/udibi.com.mx\/en\/#website","url":"https:\/\/udibi.com.mx\/en\/","name":"UDIBI","description":"IPN","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udibi.com.mx\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/1957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/comments?post=1957"}],"version-history":[{"count":2,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/1957\/revisions"}],"predecessor-version":[{"id":1959,"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/pages\/1957\/revisions\/1959"}],"wp:attachment":[{"href":"https:\/\/udibi.com.mx\/en\/wp-json\/wp\/v2\/media?parent=1957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}